| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5587133 | Diabetes Research and Clinical Practice | 2017 | 7 Pages |
Abstract
IL-33 could be considered as a potential therapeutic tool in adoptive therapies of type 1 diabetes.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Monika Ryba-StanisÅawowska, Laura Buksa, Agnieszka Brandt, Ulana Juhas, MaÅgorzata MyÅliwiec,